Repurposing Tecfidera for cancer

por Booth, Laurence, Malkin, Mark, Dent, Paul
Publicado 2016

Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies

por Dent, Paul, Booth, Laurence, Poklepovic, Andrew
Publicado 2019

Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species

por Roberts, Jane L., Poklepovic, Andrew, Booth, Laurence
Publicado 2017

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2017

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2019

GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling

por Booth, Laurence, West, Cameron, Hoff, Daniel Von, Dent, Paul
Publicado 2020

Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling

por Booth, Laurence, West, Cameron, Von Hoff, Daniel, Dent, Paul
Publicado 2021

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells

por Roberts, Jane L., Booth, Laurence, Poklepovic, Andrew, Dent, Paul
Publicado 2021

Kinase inhibitors: look beyond the label on the bottle

por Dent, Paul, Poklepovic, Andrew, Booth, Laurence, Hancock, John F.
Publicado 2019

GZ17-6.02 kills prostate cancer cells in vitro and in vivo

por Booth, Laurence, Roberts, Jane L., West, Cameron, Dent, Paul
Publicado 2022

Rationally Repurposing Ruxolitinib (Jakafi(®)) as a Solid Tumor Therapeutic

por Tavallai, Mehrad, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Publicado 2016

PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Gordon, Sarah, Dent, Paul
Publicado 2016

HDAC inhibitors enhance the immunotherapy response of melanoma cells

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Kirkwood, John, Dent, Paul
Publicado 2017

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Publicado 2020

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Publicado 2020

GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells

por Booth, Laurence, West, Cameron, Von Hoff, Daniel, Kirkwood, John M., Dent, Paul
Publicado 2021

GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins

por Booth, Laurence, West, Cameron, Moore, Robert P., Von Hoff, Daniel, Dent, Paul
Publicado 2021

GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells

por Booth, Laurence, West, Cameron, Moore, Robert P., Von Hoff, Daniel, Dent, Paul
Publicado 2022

GZ17-6.02 and axitinib interact to kill renal carcinoma cells

por Booth, Laurence, West, Cameron, Moore, Robert P., Hoff, Daniel Von, Dent, Paul
Publicado 2022

Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43

por Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Cridebring, Derek, Reiman, Eric M.
Publicado 2021